Welcome to LookChem.com Sign In|Join Free

CAS

  • or

264123-70-8

Post Buying Request

264123-70-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

264123-70-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 264123-70-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,4,1,2 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 264123-70:
(8*2)+(7*6)+(6*4)+(5*1)+(4*2)+(3*3)+(2*7)+(1*0)=118
118 % 10 = 8
So 264123-70-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H4Cl3N/c7-1-4-5(8)2-10-3-6(4)9/h2-3H,1H2

264123-70-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,5-Dichloro-4-(chloromethyl)pyridine

1.2 Other means of identification

Product number -
Other names 3,5-dichloro-4-chloromethyl-pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:264123-70-8 SDS

264123-70-8Relevant articles and documents

Compound with kinase inhibition activity and its preparation method and use

-

, (2017/08/02)

The invention discloses a compound shown in the general formula I or its pharmaceutically acceptable salt, enantiomer, diastereomer or raceme, and a preparation method and pharmacal use thereof. All groups are defined in the patent specification. The comp

8-OXY-QUINOLINE DERIVATIVES AS BRADYKININ B2 RECEPTOR MODULATORS

-

, (2008/12/04)

The present invention is related to compound of the formula (I): or a pharmacologically acceptable salt, solvate, or hydrate thereof, wherein A is a 6-membered heteroaryl having from 1 to 3 heteroatoms, each independently selected from N or O and the other substituents are defined as in the claims.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 264123-70-8